Primerdesign
Private Company
Funding information not available
Overview
Primerdesign Ltd., a subsidiary of the Novacyt Group, is a specialized molecular diagnostics company focused on the commercialization of real-time qPCR assays and integrated workflows. With over 20 years of collective expertise, the company has developed over 1,200 assays and serves customers in over 100 countries through a global distributor network. Its strategy leverages an open-platform, instrument-agnostic approach to provide flexible, high-performance detection solutions for human health, food safety, and animal health markets.
Technology Platform
Primerdesign's platform is based on expert design and validation of real-time quantitative PCR (qPCR) assays, emphasizing an open-platform, instrument-agnostic approach and integrated sample-to-result workflows.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Primerdesign competes with large integrated players (e.g., Roche, Thermo Fisher) by offering instrument-agnostic assays, and against other reagent suppliers through its deep assay design expertise and broad cross-sector portfolio. Its open-platform strategy is a key differentiator in a market with many closed systems.